AegirBio AB's total assets for Q2 2026 were kr808.26M, an increase of 30.84% from the previous quarter. DE:52Q0 total liabilities were kr345.68M for the fiscal quarter, a 73.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.